163 related articles for article (PubMed ID: 38108158)
1. Cerebrovascular reactivity in Alzheimer's disease signature regions is associated with mild cognitive impairment in adults with hypertension.
Aslanyan V; Mack WJ; Ortega NE; Nasrallah IM; Pajewski NM; Williamson JD; Pa J
Alzheimers Dement; 2024 Mar; 20(3):1784-1796. PubMed ID: 38108158
[TBL] [Abstract][Full Text] [Related]
2. Decreased Cerebrovascular Reactivity in Mild Cognitive Impairment Phenotypes.
Glass Umfleet L; Pommy J; Cohen AD; Allen M; Obarski S; Mason L; Berres H; Franczak M; Wang Y
J Alzheimers Dis; 2023; 94(4):1503-1513. PubMed ID: 37424462
[TBL] [Abstract][Full Text] [Related]
3. Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults.
Jefferson AL; Cambronero FE; Liu D; Moore EE; Neal JE; Terry JG; Nair S; Pechman KR; Rane S; Davis LT; Gifford KA; Hohman TJ; Bell SP; Wang TJ; Beckman JA; Carr JJ
Circulation; 2018 Oct; 138(18):1951-1962. PubMed ID: 30018169
[TBL] [Abstract][Full Text] [Related]
4. Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance.
Sur S; Lin Z; Li Y; Yasar S; Rosenberg P; Moghekar A; Hou X; Kalyani R; Hazel K; Pottanat G; Xu C; van Zijl P; Pillai J; Liu P; Albert M; Lu H
Neurology; 2020 Aug; 95(8):e962-e972. PubMed ID: 32661101
[TBL] [Abstract][Full Text] [Related]
5. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
6. Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials.
Henley B; Okafor M; Kulshreshtha A; Trammell A; Hajjar I
Int J Stroke; 2023 Jul; 18(6):736-744. PubMed ID: 36645213
[TBL] [Abstract][Full Text] [Related]
7. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
[TBL] [Abstract][Full Text] [Related]
8. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
Hänggi J; Streffer J; Jäncke L; Hock C
J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of type 2 diabetes and hypertension associated with cortical thinning and impaired cerebrovascular reactivity relative to hypertension alone in older adults.
Tchistiakova E; Anderson ND; Greenwood CE; MacIntosh BJ
Neuroimage Clin; 2014; 5():36-41. PubMed ID: 24967157
[TBL] [Abstract][Full Text] [Related]
10. Explainable AI-based Deep-SHAP for mapping the multivariate relationships between regional neuroimaging biomarkers and cognition.
Bhattarai P; Thakuri DS; Nie Y; Chand GB
Eur J Radiol; 2024 May; 174():111403. PubMed ID: 38452732
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
[TBL] [Abstract][Full Text] [Related]
12. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.
Thomas KR; Osuna JR; Weigand AJ; Edmonds EC; Clark AL; Holmqvist S; Cota IH; Wierenga CE; Bondi MW; Bangen KJ;
J Cereb Blood Flow Metab; 2021 May; 41(5):1001-1012. PubMed ID: 32615887
[TBL] [Abstract][Full Text] [Related]
13. Slowed Temporal and Parietal Cerebrovascular Response in Patients with Alzheimer's Disease.
Holmes KR; Tang-Wai D; Sam K; McKetton L; Poublanc J; Crawley AP; Sobczyk O; Cohn M; Duffin J; Tartaglia MC; Black SE; Fisher JA; Wasserman B; Mikulis DJ
Can J Neurol Sci; 2020 May; 47(3):366-373. PubMed ID: 32051047
[TBL] [Abstract][Full Text] [Related]
14. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
15. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
16. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
van de Mortel LA; Thomas RM; van Wingen GA;
J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
[TBL] [Abstract][Full Text] [Related]
17. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).
Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F
Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024
[TBL] [Abstract][Full Text] [Related]
18. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
Alegret M; Cuberas-Borrós G; Espinosa A; Valero S; Hernández I; Ruíz A; Becker JT; Rosende-Roca M; Mauleón A; Sotolongo O; Castell-Conesa J; Roca I; Tárraga L; Boada M
J Alzheimers Dis; 2014; 41(3):739-48. PubMed ID: 24685632
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
Mao C; You H; Hou B; Chu S; Jin W; Huang X; Shang L; Feng F; Peng B; Gao J
J Alzheimers Dis; 2023; 93(2):509-519. PubMed ID: 37038812
[TBL] [Abstract][Full Text] [Related]
20. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
